Welcome to visit AIMA International Group
Spain
Your browser version is too low, in order to ensure a better browsing experience，Please click to update to a higher version browser.
Talk about it later.XWelcome to visit AIMA International Group
Spain
PDRN ampoules have quietly become the workhorse of medical aesthetics wholesale catalogs. If you have been tracking FDA approved PDRN ampoule wholesale deals, you already know the market is crowded with options — and not all of them carry the regulatory paperwork that serious clinics demand. This guide cuts through the noise. We break down what FDA approved PDRN ampoule wholesale actually means in practice, how 2026 pricing compares across product tiers, and which three AIMA International SKUs are moving fastest into European and Southeast Asian clinics right now.
Let us be blunt about terminology. PDRN (polydeoxyribonucleotide) is derived from salmon or trout sperm DNA. In the United States, the FDA has not approved any PDRN product for injectable use as a cosmetic device. What you will see labeled “FDA approved” in the wholesale channel usually means one of two things:
1) The manufacturing facility holds FDA establishment registration and the product was cleared through the 510(k) pathway as a Class II medical device — this is the gold standard, and it is rare for PDRN injectables. 2) The brand markets the product as “FDA-compliant” because it is manufactured in an FDA-registered GMP facility and meets USP standards for purity, sterility, and labeling — but the product itself may be classified as a dietary supplement or a cosmetic ingredient depending on the route of administration.
For wholesale buyers, the practical takeaway is simple: always ask for the FDA registration number, the 510(k) clearance letter (if claimed), and the Certificate of Analysis (COA) from an ISO 17025-accredited lab. AIMA International maintains FDA establishment registration and manufactures all PDRN ampoules in its Class 100 GMP workshop, with third-party SGS testing on every batch.
Related reading: What Is PDRN in Skin Care — A Complete Guide
The global PDRN market is projected to reach $680 million by 2028, up from roughly $340 million in 2023, according to Grand View Research. Two forces are driving this:
Regulatory tightening in the EU. The EU MDR 2017/745 transition deadline has pushed many smaller manufacturers out of the injectable space. Clinics that previously bought from unverified factories now face a compliance gap — and they are turning to established OEMs with existing CE marks and MDR documentation.
Consumer demand for DNA-based rejuvenation. PDRN stimulates tissue regeneration through adenosine receptor activation (A2A and A2B). In plain language: it tells your fibroblasts to produce more collagen and elastin. Clinical studies published in Journal of Cosmetic Dermatology (2023) showed significant improvement in skin hydration and elasticity after a 3-session PDRN mesotherapy protocol. Patients are asking for it. Clinics need a reliable wholesale source.
This is exactly where FDA approved PDRN ampoule wholesale becomes a strategic purchase decision rather than a commodity grab.
Based on AIMA International’s current wholesale catalog, here are the three PDRN ampoule SKUs that dominate our order volume — and the pricing that buyers can expect for 2026.
This is the bread-and-butter PDRN mesotherapy ampoule. Each vial contains pharmaceutical-grade PDRN at a concentration optimized for intradermal injection. The ampoule format (as opposed to pre-filled syringe) gives practitioners flexibility in dosing and allows them to mix PDRN with other actives — lidocaine, vitamins, or glutathione — depending on the patient’s skin concern.
Key specs: PDRN concentration | Ampoule format (1 vial per box) | Sterile, pyrogen-free | GMP Class 100 manufacturing | SGS tested | CE marked
Wholesale price: $40/pc (MOQ applies — contact for volume tiers)
Best for: Clinics running PDRN mesotherapy as a standalone treatment or as a booster in combination protocols. Popular in the UK, Germany, and UAE markets where PDRN is classified as a Class IIb medical device.
This SKU takes the base PDRN formula and combines it with hyaluronic acid and a blend of amino acids. The result is a dual-action product: PDRN drives cellular regeneration while HA provides immediate hydration and volumetric support. It sits in the “skin booster” category and is marketed as a comprehensive rejuvenation treatment rather than a pure PDRN injection.
Key specs: PDRN + HA + amino acids | Pre-filled syringe | GMP Class 100 | CE marked | MDR 2017/745 compliant
Wholesale price: $40/pc
Best for: Aesthetic clinics targeting patients who want “glow” treatments — fine line improvement, pore refinement, and overall skin quality enhancement. This product has been a top seller in South Korea and Japan, and demand is growing rapidly in the US market where PDRN is sold as a compounded ingredient.
The third member of the PDRN family adds niacinamide and glutathione to the PDRN base. This formulation targets hyperpigmentation, post-inflammatory erythema, and uneven skin tone — concerns that are particularly prevalent in Fitzpatrick skin types III-VI. For clinics serving diverse patient populations, this is often the first PDRN product they stock.
Key specs: PDRN + niacinamide + glutathione | Pre-filled syringe | GMP Class 100 | CE marked | MDR 2017/745 compliant
Wholesale price: $40/pc
Best for: Dermatology and aesthetics clinics focusing on pigmentation correction. The combination of PDRN’s regenerative properties with melanin-inhibiting actives creates a treatment that addresses both the cause and the visible sign of discoloration.
Here is a quick reference for all three products side by side:
| Product | Category | Format | Wholesale Price (2026) |
|---|---|---|---|
| OTESALY MESO PDRN Ampoule | Pure PDRN | Ampoule | $40/pc |
| OTESALY MESO Skin Rejuvenating PDRN | PDRN + HA | Syringe | $40/pc |
| OTESALY MESO Skin Brightening PDRN | PDRN + Niacinamide | Syringe | $40/pc |
Note: Prices are reference wholesale prices and may vary based on order volume, customization requirements, and shipping terms. Contact AIMA International for a formal quotation.
A clinic owner in Dubai shared this with me last year: her previous supplier quoted her 30% below market for PDRN ampoules. She signed a 500-unit PO. When the shipment arrived, the COA listed a different manufacturer than the one on the label, and the lot numbers did not match the CE certificate. Customs held the goods for three weeks. She lost two months of treatment slots and had to refund prepaid packages to her patients. The total cost of that “deal” — including lost revenue, reputational damage, and the emergency reorder from AIMA — was roughly 4.2 times the original savings.
When you source FDA approved PDRN ampoule wholesale, the cheapest unit price is almost always the most expensive decision in the long run. AIMA provides complete documentation packs with every order: FDA establishment registration, CE certificate, MDR 2017/745 technical file, ISO 13485 certificate, batch-specific COA, and MSDS. Our compliance team also assists with import licensing in your target market.
Before you commit to a PDRN ampoule wholesale contract, run your potential supplier through this checklist:
AIMA International was founded in 2003. Over 23 years, the company has grown from a small mesotherapy manufacturer to a Top 10 global dermal filler producer with a 4,800m² manufacturing base, 1,000+ mature formulas, and private label solutions for 521+ brands across 50+ countries. Here is what that track record means for you as a wholesale buyer:
For clinics and distributors building a PDRN product line, here is a realistic cost framework:
These prices are among the most competitive in the FDA approved PDRN ampoule wholesale segment, and they are backed by documentation that would be impossible to replicate with low-cost, unregulated manufacturers. When you factor in the cost of regulatory risk, the AIMA pricing structure delivers genuine value.
The FDA approved PDRN ampoule wholesale market is maturing fast. Price alone should never be your deciding factor — regulatory documentation, manufacturing transparency, and after-sales support are what separate a reliable partner from a risky commodity trader.
AIMA International brings 23 years of manufacturing expertise, Class III medical device licensing, 521+ brand success stories, and wholesale pricing that competes confidently in the global market. Whether you need a single trial batch or a 5,000-unit private label order, the infrastructure is in place to deliver.
Copyright @ 2026 AIMA International Group Co., Ltd.
